

Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Micardis - tablets:
1 tab. contains telmisartan 40 and 80 mg; excipients: polyvidone; meglumine; sodium hydroxide; sorbitol; Magnesium stearate;
Pack of 14, 28, 56 or 98 pcs.
Micardis has a hypotensive effect.
Arterial hypertension.
Hypersensitivity, impaired biliary tract patency, marked impaired liver or kidney function, hereditary fructose intolerance, pregnancy, breastfeeding, children and adolescents.
Of the nervous system: headache, dizziness, fatigue, insomnia, anxiety, depression, convulsions.
On the part of the respiratory system: upper respiratory tract infections (including pharyngitis, sinusitis, bronchitis), cough.
Cardiovascular: marked lowering of blood pressure, bradycardia, tachycardia, chest pain.
On the part of the digestive system: nausea, dyspepsia, diarrhea, abdominal pain, increased activity of "liver" transaminases.
On the part of the musculoskeletal system: myalgia, arthralgia, back pain, symptoms of tendonitis.
On the part of the urinary system: peripheral edema, urinary tract infection, hypercreatininemia.
Allergic reactions: skin rash, etc.
Laboratory indicators: rarely - hyperkalemia, anemia or hyperuricemia.
Other: flu-like syndrome, rarely - erythema, pruritus, syncope, dyspnea, eosinophilia, thrombocytopenia, angioedema, urticaria.
Micardis is taken orally, regardless of the meal. Adults - 40 mg 1 time per day. In some patients, a therapeutic effect can be achieved by using a dose of 20 mg / day. In the absence of a decrease in blood pressure to the desired level, the dose may be increased to 80 mg once a day. The maximum effectiveness of the hypotensive action of Micardis is usually noted 4-8 weeks after the start of treatment. Patients with severe hypertension - up to 160 mg / day or in combination with hydrochlorothiazide 12.5-25 mg / day.
In the dark place at a temperature of no higher than 20 ° C.